Neuroone Medical Technologies (NMTC) Short term Debt (2016 - 2024)
Neuroone Medical Technologies' (NMTC) quarterly Short term Debt came in at $121896.0 in Q1 2024, down 5.59% on a QoQ basis from $129116.0 in Q3 2023.
Neuroone Medical Technologies (NMTC) Short term Debt (2016 - 2024) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 6 years of Short term Debt data on file, last reported at $121896.0 in Q1 2024.
- Quarterly Short term Debt changed N/A year-over-year to $121896.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $121896.0 (changed N/A YoY) and the FY2023 annual result came in at $129116.0, changed N/A from the prior year.
- Short term Debt fell to $121896.0 in Q1 2024, from $129116.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $129116.0 in Q3 2023 to a low of $121896.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.48 Bn | 196.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.02 Bn | 123.54 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.52 Bn | 73.98 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.81 Bn | 47.55 Bn | 1.35 Bn |
| 6 | Dexcom | 34.91 Bn | 32.96 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.82 Bn | 31.71 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.29 Bn | 22.97 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 18.19 Mn | 16.14 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 121,896.00 |
| Sep 30, 2023 | 129,116.00 |
| Mar 31, 2019 | 229,000.00 |
| Dec 31, 2018 | 528,000.00 |
| Sep 30, 2018 | 283,000.00 |
| Jun 30, 2018 | 283,000.00 |
| Mar 31, 2018 | 369,124.00 |
| Dec 31, 2017 | 253,000.00 |
| Sep 30, 2017 | 204,074.00 |
| Dec 31, 2016 | 50,000.00 |